HBV-IN-41
HBV-IN-41 (compound 45) is a potent and orally active Hepatitis B Virus (HBV) inhibitor, with an EC50 of 0.027μM[1].
Product Specifications
CAS Number
[1967002-25-0]
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hbv-in-41.html
Solubility
10 mM in DMSO
Smiles
C[C@H]1CN2C(CN1C(NC3=CC(Cl)=C(C=C3)F)=O)=C(C=N2)N4CCOCC4=O
Molecular Formula
C18H19ClFN5O3
Molecular Weight
407.83
References & Citations
[1]Kou B, et al. Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus. J Med Chem. 2023 Oct 6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6351138-01 0.2 mL
SREBF2, ID (SREBF2, BHLHD2, SREBP2, Sterol regulatory element-binding protein 2, Class D basic helix-loop-helix protein 2, Sterol regulatory element-binding transcription factor 2, Processed sterol regulatory element-binding protein 2) (Biotin)
Ask
View Details MBS6351138-02 5x 0.2 mL
SREBF2, ID (SREBF2, BHLHD2, SREBP2, Sterol regulatory element-binding protein 2, Class D basic helix-loop-helix protein 2, Sterol regulatory element-binding transcription factor 2, Processed sterol regulatory element-binding protein 2) (Biotin)
Ask
View Details